By Editor , 17 September 2026
MobileX Launches Hybrid Wireless Model, Debuts CallSign Mobile for Veterans

Irvine, Calif. and Brooklyn, N.Y. – September 17, 2026 -- MobileX has introduced a hybrid retail model that lets third-party brands launch their own wireless services on its network infrastructure, with veteran-founded CallSign Mobile becoming the first company to go live under the new framework.

By Editor , 17 September 2026
GMA, RMI, 3Degrees Launch Buyers Alliance for Green Ammonia

Washington – September 17, 2026 -- The Center for Green Market Activation (GMA), RMI, and 3Degrees have launched the Green Ammonia Buyers Alliance (GABA), a collective procurement initiative targeting emissions from fertilizer manufacturing, one of the largest contributors to the sector's estimated 1.2 gigatons of annual CO2e output.

By Editor , 17 September 2026
NextEra Reaffirms 8%+ EPS Growth, Targets High End of 2026 Guidance

Juno Beach, Fla. – September 17, 2026 -- NextEra Energy said it is targeting the high end of its 2026 adjusted earnings per share guidance range of $3.92 to $4.02, as senior executives prepare to meet investors through early October to detail growth prospects tied to its pending combination with Dominion Energy.

By Editor , 17 September 2026
Corteva Board Approves Vylor Spin-Off, Sets Oct. 1 Distribution

Indianapolis – September 17, 2026 -- Corteva's Board of Directors has approved the separation of the company's seed operating segment into a new independent, publicly traded entity, Vylor Inc., with the stock distribution scheduled for October 1, 2026.

By Editor , 17 September 2026
NexPhase Capital Invests in EVERYWHERE Communications Platform

New York – September 17, 2026 -- NexPhase Capital, LP has made an investment in EVERYWHERE Communications, a mission-critical software platform serving government and enterprise clients across more than 175 countries. Terms of the deal were not disclosed.

By Editor , 17 September 2026
Acurx Poster Shows Ibezapolstat Beats Vancomycin in C. diff-VRE Co-Cultures

Staten Island, N.Y. – September 17, 2026 -- Acurx Pharmaceuticals (NASDAQ: ACXP) presented new in vitro data showing its lead antibiotic ibezapolstat achieved a 5.51-log reduction against Clostridioides difficile in co-culture with vancomycin-resistant Enterococcus (VRE), significantly outperforming vancomycin (p=0.0112), the current standard of care.

The poster, presented by Dr. Eugenie Bassères of the University of Houston College of Pharmacy, was unveiled at the 9th International C. difficile Symposium in Bled, Slovenia, held September 8-10, 2026.

By Editor , 17 September 2026
FDA Grants Breakthrough Therapy Status to Armata's AP-SA02 Phage Drug

Los Angeles – September 17, 2026 -- The U.S. Food and Drug Administration has granted Breakthrough Therapy designation to Armata Pharmaceuticals' AP-SA02, an intravenous multi-phage candidate for complicated Staphylococcus aureus bacteremia, stacking the designation atop existing Fast Track and Qualified Infectious Disease Product status.

By Editor , 17 September 2026
The Systems Group Launches Steel-Mill-Only HVAC Division

Little Rock, Ark. – September 17, 2026 -- The Systems Group (TSG), a family-owned steel-industry service provider founded in 1970, has launched Systems Cool Air Solutions, an eighth operating division dedicated exclusively to HVAC work at steel mills and metal-related industrial facilities.

By Editor , 17 September 2026
PRC-Saltillo Launches Genesis AAC Devices, Shipping in October

Wooster, Ohio – September 17, 2026 -- PRC-Saltillo has launched its Genesis product line globally, introducing two Windows-based augmentative and alternative communication (AAC) devices for individuals with acquired or long-term complex communication needs, including ALS and cerebral palsy.